Baxter International Inc (BAX) stock
BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/304% above fair value
$25.81+0.07 (+0.27%)
Close on Nov 13, 2026Market cap $13.35BP/E –Yield 2.01%
Baxter International cash
Cash and short-term investments held at the end of each period.
Baxter International's cash was $1.98B at Sep 30, 2026. For fiscal 2025 it was $1.97B, up 11.5% from the year before. Over ten years it grew -12.4% a year on average. The highest annual figure on record is $7.36B in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.97B | +11.5% |
| FY2024 | Dec 31, 2024 | $1.76B | -42.7% |
| FY2023 | Dec 31, 2023 | $3.08B | +89.9% |
| FY2022 | Dec 31, 2022 | $1.62B | -45.1% |
| FY2021 | Dec 31, 2021 | $2.95B | -21.0% |
| FY2020 | Dec 31, 2020 | $3.74B | +12.0% |
| FY2019 | Dec 31, 2019 | $3.34B | +81.4% |
| FY2018 | Dec 31, 2018 | $1.84B | -46.0% |
| FY2017 | Dec 31, 2017 | $3.40B | +22.1% |
| FY2016 | Dec 31, 2016 | $2.79B | -62.2% |
| FY2015 | Dec 31, 2015 | $7.36B | +151.7% |
| FY2014 | Dec 31, 2014 | $2.93B | +7.0% |
| FY2013 | Dec 31, 2013 | $2.73B | -16.4% |
| FY2012 | Dec 31, 2012 | $3.27B | +12.6% |
| FY2011 | Dec 31, 2011 | $2.91B | +8.2% |
| FY2010 | Dec 31, 2010 | $2.69B | -3.6% |
| FY2009 | Dec 31, 2009 | $2.79B | +30.7% |
| FY2008 | Dec 31, 2008 | $2.13B | -16.1% |
| FY2007 | Dec 31, 2007 | $2.54B | +2.2% |
| FY2006 | Dec 31, 2006 | $2.49B | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.98B | +14.4% |
| Q2 FY2026 | Jun 30, 2026 | $2.15B | +27.5% |
| Q1 FY2026 | Mar 31, 2026 | $2.02B | -12.1% |
| Q4 FY2025 | Dec 31, 2025 | $1.97B | +11.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.73B | +21.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.69B | +7.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.29B | -18.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.76B | -42.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.42B | -75.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.57B | -8.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.83B | +68.9% |
| Q4 FY2023 | Dec 31, 2023 | $3.08B | +89.9% |
| Q3 FY2023 | Sep 30, 2023 | $5.72B | +257.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.72B | -7.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.67B | -27.1% |
| Q4 FY2022 | Dec 31, 2022 | $1.62B | -45.1% |
| Q3 FY2022 | Sep 30, 2022 | $1.60B | -50.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.85B | -40.9% |
| Q1 FY2022 | Mar 31, 2022 | $2.29B | -27.9% |
| Q4 FY2021 | Dec 31, 2021 | $2.95B | -21.0% |
| Q3 FY2021 | Sep 30, 2021 | $3.26B | -25.3% |
| Q2 FY2021 | Jun 30, 2021 | $3.14B | -23.2% |
| Q1 FY2021 | Mar 31, 2021 | $3.18B | -22.6% |
| Q4 FY2020 | Dec 31, 2020 | $3.74B | +12.0% |
| Q3 FY2020 | Sep 30, 2020 | $4.36B | +44.9% |
| Q2 FY2020 | Jun 30, 2020 | $4.09B | +39.2% |
| Q1 FY2020 | Mar 31, 2020 | $4.11B | +116.1% |
| Q4 FY2019 | Dec 31, 2019 | $3.34B | +81.4% |
| Q3 FY2019 | Sep 30, 2019 | $3.01B | +5.1% |
| Q2 FY2019 | Jun 30, 2019 | $2.93B | +2.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.90B | -35.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.84B | -46.0% |
| Q3 FY2018 | Sep 30, 2018 | $2.86B | -18.6% |
| Q2 FY2018 | Jun 30, 2018 | $2.86B | -25.1% |
| Q1 FY2018 | Mar 31, 2018 | $2.95B | +3.2% |
| Q4 FY2017 | Dec 31, 2017 | $3.40B | +22.1% |
| Q3 FY2017 | Sep 30, 2017 | $3.52B | – |
| Q2 FY2017 | Jun 30, 2017 | $3.82B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.86B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.79B | – |
See a number that looks wrong?